Top in cardiology: Sleep apnea and AF, Kawasaki disease
Researchers reported that sleep apnea is often undiagnosed in patients with atrial fibrillation despite its prevalence in this patient population. It was the top story in cardiology last week.
Another top story was based on a study that showed corticosteroids combined with standard treatment for patients with Kawasaki disease reduced the risk for coronary artery abnormalities.
Read these and more top stories in cardiology below:
Sleep apnea common in AF, often undiagnosed
Despite its prevalence in patients with atrial fibrillation (AF), sleep apnea is often undiagnosed in this patient population, researchers found. The study, published in JACC: Clinical Electrophysiology, also showed that standard questionnaires to identify patients with sleep apnea have limited predictive value in patients with AF. Read more.
Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease
Corticosteroids with standard treatment for patients with Kawasaki disease reduced the risk for coronary artery abnormalities and treatment failure, researchers found. Read more.
Sacubitril/valsartan improves renal outcomes in HFpEF, chronic kidney disease
Sacubitril/valsartan (Entresto, Novartis) was superior to valsartan alone for reduction of renal events in patients with heart failure and preserved ejection fraction and chronic kidney disease, researchers reported. Read more.
Coronary CTA superior to stress myocardial perfusion imaging for invasive FFR diagnosis
Using coronary CT angiography for comprehensive anatomic interpretation was superior to functional imaging to determine fractional flow reserve, according to data from the CREDENCE trial. Read more.
Plant-based meat products reduce trimethylamine-N-oxide, other CVD risk factors
Replacing animal meat with plant-based alternatives improved several CVD risk factors, including trimethylamine-N-oxide, in generally healthy participants compared with a diet with animal meat, researchers found in the SWAP-MEAT trial. Read more.